Ailin Zhao

1.1k total citations · 1 hit paper
47 papers, 519 citations indexed

About

Ailin Zhao is a scholar working on Pathology and Forensic Medicine, Oncology and Hematology. According to data from OpenAlex, Ailin Zhao has authored 47 papers receiving a total of 519 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pathology and Forensic Medicine, 14 papers in Oncology and 13 papers in Hematology. Recurrent topics in Ailin Zhao's work include Lymphoma Diagnosis and Treatment (14 papers), Multiple Myeloma Research and Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Ailin Zhao is often cited by papers focused on Lymphoma Diagnosis and Treatment (14 papers), Multiple Myeloma Research and Treatments (7 papers) and Chronic Lymphocytic Leukemia Research (6 papers). Ailin Zhao collaborates with scholars based in China, United States and Germany. Ailin Zhao's co-authors include Kai Kang, Yijun Wu, Ting Niu, Li J, Xinxin Cao, Daobin Zhou, Jinrong Yang, Minghui Duan, Hui Zhou and Meng Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Frontiers in Immunology.

In The Last Decade

Ailin Zhao

43 papers receiving 507 citations

Hit Papers

1 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dual blockade immunotherapy targeting PD-1/PD-L1 and CTLA-4 in lung cancer

2024 73 citations Kai Kang, Ailin Zhao et al. Journal of Hematology & Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Ailin Zhao China	13	166	107	100	92	91	47	519
Edward R. Scheffer Cliff United States	12	335 2.0×	140 1.3×	99 1.0×	78 0.8×	45 0.5×	59	576
Ryan A. Metcalf United States	12	72 0.4×	75 0.7×	93 0.9×	25 0.3×	71 0.8×	44	460
Vanessa E. Kennedy United States	15	232 1.4×	177 1.7×	277 2.8×	208 2.3×	19 0.2×	45	843
Édouard Cornet France	16	150 0.9×	128 1.2×	139 1.4×	191 2.1×	102 1.1×	76	749
B. Tiangco Philippines	11	255 1.5×	85 0.8×	21 0.2×	41 0.4×	21 0.2×	21	495
Franklin Fuda United States	11	71 0.4×	75 0.7×	145 1.4×	46 0.5×	8 0.1×	51	395
Felix Keil Austria	12	112 0.7×	50 0.5×	226 2.3×	103 1.1×	18 0.2×	25	450
Junru Liu China	14	163 1.0×	227 2.1×	215 2.1×	38 0.4×	26 0.3×	79	555
Luigino Boschiero Italy	16	278 1.7×	70 0.7×	11 0.1×	50 0.5×	28 0.3×	36	746

Countries citing papers authored by Ailin Zhao

Since Specialization

Citations

This map shows the geographic impact of Ailin Zhao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailin Zhao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailin Zhao more than expected).

Fields of papers citing papers by Ailin Zhao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailin Zhao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailin Zhao. The network helps show where Ailin Zhao may publish in the future.

Co-authorship network of co-authors of Ailin Zhao

This figure shows the co-authorship network connecting the top 25 collaborators of Ailin Zhao. A scholar is included among the top collaborators of Ailin Zhao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailin Zhao. Ailin Zhao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bai, Hexiang, et al.. (2025). Evaluation of anti-CD38 monoclonal antibody-based immunotherapy in multiple myeloma with renal insufficiency: a systematic review and meta-analysis. Therapeutic Advances in Hematology. 16. 1584237353–1584237353. 1 indexed citations

Yang, Yuqi, Yijun Wu, Kai Kang, et al.. (2024). Transformation risk and associated survival outcome of marginal zone lymphoma: A nationwide study. Annals of Hematology. 103(10). 4211–4222. 2 indexed citations

Wang, Jinjin, Jinrong Yang, Yu‐Hui Chen, et al.. (2024). Adult acute leukemia patients with gram-negative bacteria bloodstream infection: Risk factors and outcomes of antibiotic-resistant bacteria. Annals of Hematology. 103(10). 4021–4031. 4 indexed citations

Zheng, Yue, et al.. (2024). Rare and complex diseases in focus: ChatGPT's role in improving diagnosis and treatment. Frontiers in Artificial Intelligence. 7. 1338433–1338433. 10 indexed citations

Zhang, Chunlan, et al.. (2024). Survival trend and outcome prediction for pediatric Hodgkin and non-Hodgkin lymphomas based on machine learning. Clinical and Experimental Medicine. 24(1). 132–132.

Wu, Yijun, Kai Kang, Yuqi Yang, et al.. (2024). Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms. Journal of Hematology & Oncology. 17(1). 106–106. 17 indexed citations

Wang, Hua, Yuqiong Wu, Yushun Zhang, et al.. (2023). Uncertainty and explainable analysis of machine learning model for reconstruction of sonic slowness logs. SHILAP Revista de lepidopterología. 4. 182–198. 4 indexed citations

Wu, Yijun, Zhile Wang, Yuqi Yang, et al.. (2023). Exploration of potential novel drug targets and biomarkers for small cell lung cancer by plasma proteome screening. Frontiers in Pharmacology. 14. 1266782–1266782. 11 indexed citations

Zhao, Ailin, Hui Zhou, Jinrong Yang, Meng Li, & Ting Niu. (2023). Epigenetic regulation in hematopoiesis and its implications in the targeted therapy of hematologic malignancies. Signal Transduction and Targeted Therapy. 8(1). 71–71. 62 indexed citations

10.

Zhao, Ailin & Yijun Wu. (2023). Future implications of ChatGPT in pharmaceutical industry: drug discovery and development. Frontiers in Pharmacology. 14. 1194216–1194216. 25 indexed citations

11.

Yang, Tao, Ailin Zhao, Mingsong Shi, et al.. (2022). Preclinical studies of Flonoltinib Maleate, a novel JAK2/FLT3 inhibitor, in treatment of JAK2V617F-induced myeloproliferative neoplasms. Blood Cancer Journal. 12(3). 37–37. 9 indexed citations

12.

Xu, Yan, et al.. (2022). Effect of time-varying transverse stresses on the bond-slip and global behavior of RC members under monotonic loads. Journal of Building Engineering. 59. 105045–105045. 3 indexed citations

13.

Zhao, Ailin, Jinrong Yang, Meng Li, et al.. (2022). Epstein-Barr Virus-Positive Lymphoma-Associated Hemophagocytic Syndrome: A Retrospective, Single-Center Study of 51 Patients. Frontiers in Immunology. 13. 882589–882589. 7 indexed citations

14.

Wang, Jinjin, Hui Zhou, Ailin Zhao, et al.. (2022). Efficacy and safety of copanlisib in relapsed/refractory B-cell non-Hodgkin lymphoma: A meta-analysis of prospective clinical trials. Frontiers in Immunology. 13. 1034253–1034253. 5 indexed citations

15.

Wu, Yijun, Zhuoran Yao, Jianhui Zhang, et al.. (2022). Real-world landscape transition of death causes in the immunotherapy era for metastatic non-small cell lung cancer. Frontiers in Immunology. 13. 1058819–1058819. 1 indexed citations

16.

Cao, Xinxin, Minghui Duan, Ailin Zhao, et al.. (2021). Treatment outcomes and prognostic factors of patients with adult Langerhans cell histiocytosis. American Journal of Hematology. 97(2). 203–208. 27 indexed citations

17.

Zhao, Ailin, Minghui Duan, Hao Cai, et al.. (2021). Diverse kinase alterations and myeloid-associated mutations in adult histiocytosis. Leukemia. 36(2). 573–576. 34 indexed citations

18.

Wang, Qin, Lu Zhang, Hao Sun, et al.. (2021). Histogram Analysis Based on Apparent Diffusion Coefficient Maps of Bone Marrow in Multiple Myeloma: An Independent Predictor for High-risk Patients Classified by the Revised International Staging System. Academic Radiology. 29(6). e98–e107. 4 indexed citations

19.

Wang, Jinjin, et al.. (2020). Risk of Bleeding Associated With Ibrutinib in Patients With B-Cell Malignancies: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology. 11. 580622–580622. 12 indexed citations

20.

Zhao, Ailin, et al.. (2019). <p>Early or deferred treatment of smoldering multiple myeloma: a meta-analysis on randomized controlled studies</p>. Cancer Management and Research. Volume 11. 5599–5611. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact